BPS Bioscience Inc.
中级会员 | 第3年

当前位置:BPS Bioscience Inc.>>CAR T-Cell Therapy Cell Lines>> 78772MART-1 TCR (DMF4) CD8+ NFAT-Luciferase Reporter Jurkat Cell Line

MART-1 TCR (DMF4) CD8+ NFAT-Luciferase Reporter Jurkat Cell Line

参  考  价面议
具体成交价以合同协议为准

产品型号78772

品       牌BPS Bioscience

厂商性质生产商

所  在  地

更新时间:2023-11-11 19:47:07浏览次数:248次

联系我时,请告知来自 化工仪器网
同类优质产品更多>
●Purchase●DescriptionThiscelllinewasgeneratedfromtheTCellReceptor(TCR)KnockoutNFATLuciferaseReporterJurkatCellLine(BPSBioscience#78556)byoverexpressionofhumanCD8(NM_001768
Purchase
Description

This cell line was generated from the T Cell Receptor (TCR) Knockout NFAT Luciferase Reporter Jurkat Cell Line (BPS Bioscience #78556) by overexpression of human CD8 (NM_001768.6) and MART-1-specific TCR (DMF4) using lentiviral transduction (CD8a Lentivirus #78648 and MART-1-Specific TCR Lentivirus Clone DMF4 #78678). The human TCR clone DMF4 specifically recognizes tumor antigen MART-1 (Melanoma-associated antigen recognized by T cells-1, or Melan-A).

Figure 1: Illustration of the functional co-culture assay used to validate the MART-1 TCR (DMF4) CD8+ NFAT-Luciferase Reporter Jurkat cell line.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

会员登录

×

请输入账号

请输入密码

=

请输验证码

收藏该商铺

X
该信息已收藏!
标签:
保存成功

(空格分隔,最多3个,单个标签最多10个字符)

常用:

提示

X
您的留言已提交成功!我们将在第一时间回复您~
拨打电话
在线留言